Italia markets closed
FTSE MIB
35.398,82 -11,31 (-0,03%) Dow Jones
40.003,59 +134,21 (+0,34%) Nasdaq
16.685,97 -12,35 (-0,07%) Nikkei 225
38.787,38 -132,88 (-0,34%) Petrolio
80,00 +0,77 (+0,97%) Bitcoin EUR
61.593,36 +1.619,78 (+2,70%)
DaVita Inc. (DVA)
NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 136,48 |
| Aperto | 137,15 |
| Denaro | 139,90 x 1400 |
| Lettera | 139,80 x 900 |
| Min-Max giorno | 137,02 - 140,44 |
| Intervallo di 52 settimane | 71,51 - 145,04 |
| Volume | |
| Media Volume | 795.800 |
| Capitalizzazione | 12,263B |
| Beta (5 anni mensile) | 1,03 |
| Rapporto PE (ttm) | 15,85 |
| EPS (ttm) | 8,82 |
| Prossima data utili | 01 ago 2024 - 05 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 145,07 |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.